Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A case of multiple evanescent white dot syndrome misdiagnosed as optic neuritis: Differential diagnosis for the neurologist.
Vision Disturbances in Multiple Sclerosis.
Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?
Dimethyl Fumarate Inhibits the Nuclear Factor kappaB Pathway in Breast Cancer Cells by Covalent Modification of p65.
Neurological involvement in Primary Sjögren Syndrome.
Ampyra (Fampyra)
The cell biology of CNS myelination.
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice.
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.
CNS vasculitis in a patient with MS on daclizumab monotherapy.
Clinical proteomics of enervated neurons.
Erratum to: Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
Multiple sclerosis review.
UCSF Seminar: "How do we get a myelinated brain? A new model for distribution of oligodendrocytes throughout the developing CNS"
Advanced Structural and Functional Brain MRI in Multiple Sclerosis.
Data supporting the role of Fyn in initiating myelination in the peripheral nervous system.
Comparative miRNA-Based Fingerprinting Reveals Biological Differences in Human Olfactory Mucosa- and Bone-Marrow-Derived Mesenchymal Stromal Cells.
Dimethyl fumarate (BG-12, Tecfidera) approved for use by the NHS in Scotland
The impact of multiple sclerosis relapse treatment on migration of effector T cells - Preliminary study.
Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Central fatigue in multiple sclerosis: a review of the literature.
Multiple Sclerosis and Catastrophic Health Expenditure in Iran.
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study.

Pages